Skip Navigation
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

National Institute of Environmental Health Sciences

Use this QR code to view the newest version of this document
Use this QR code to view the newest version of this document

Your Environment. Your Health.

Publication Detail

Title: Effect of nonalcoholic steatohepatitis on renal filtration and secretion of adefovir.

Authors: Laho, Tomas; Clarke, John D; Dzierlenga, Anika L; Li, Hui; Klein, David M; Goedken, Michael; Micuda, Stanislav; Cherrington, Nathan J

Published In Biochem Pharmacol, (2016 Sep 01)

Abstract: Adefovir, an acyclic nucleotide reverse transcriptase inhibitor used to treat hepatitis B viral infection, is primarily eliminated renally through cooperation of glomerular filtration with active tubular transport. Nonalcoholic steatohepatitis is a variable in drug disposition, yet the impact on renal transport processes has yet to be fully understood. The goal of this study was to determine the effect of nonalcoholic steatohepatitis on the pharmacokinetics of adefovir in rats given a control or methionine and choline deficient diet to induce nonalcoholic steatohepatitis.Animals received a bolus dose of 7mg/kg (35μCi/kg) [(3)H] adefovir with consequent measurement of plasma and urine concentrations. Inulin clearance was used to determine glomerular filtration rate.Methionine and choline deficient diet-induced nonalcoholic steatohepatitis prolonged the elimination half-life of adefovir. This observation occurred in conjunction with reduced distribution volume and hepatic levels of adefovir. Notably, despite these changes, renal clearance and overall clearance were not changed, despite markedly reduced glomerular filtration rate in nonalcoholic steatohepatitis. Alteration of glomerular filtration rate was fully compensated for by a significant increase in tubular secretion of adefovir. Analysis of renal transporters confirmed transcriptional up-regulation of Mrp4, the major transporter for adefovir tubular secretion.This study demonstrates changes to glomerular filtration and tubular secretion that alter pharmacokinetics of adefovir in nonalcoholic steatohepatitis. Nonalcoholic steatohepatitis-induced changes in renal drug elimination processes could have major implications in variable drug response and the potential for toxicity.

PubMed ID: 27381944 Exiting the NIEHS site

MeSH Terms: Adenine/analogs & derivatives*; Adenine/pharmacokinetics; Animals; Choline/administration & dosage; Diet; Glomerular Filtration Rate; Kidney/drug effects*; Kidney/metabolism; Male; Methionine/administration & dosage; Non-alcoholic Fatty Liver Disease/metabolism*; Organophosphonates/pharmacokinetics*; Rats; Rats, Sprague-Dawley; Reverse Transcriptase Inhibitors/pharmacokinetics*

Back
to Top